Literature DB >> 21685926

Proteomic alterations in mouse kidney induced by andrographolide sodium bisulfite.

Hong Lu1, Xin-yue Zhang, Yan-quan Zhou, Xin Wen, Li-ying Zhu.   

Abstract

AIM: To identify the key proteins involved in the nephrotoxicity induced by andrographolide sodium bisulfite (ASB).
METHODS: Male ICR mice were intravenously administrated with ASB (1000 or 150 mg·kg⁻¹·d⁻¹) for 7 d. The level of malondialdehyde (MDA) and the specific activity of superoxide dismutase (SOD) in kidneys were measured. The renal homogenates were separated by two-dimensional electrophoresis, and the differential protein spots were identified using a matrix-assisted laser desorption/ionization (MALDI) time-of-flight (TOF)/TOF mass spectrometry.
RESULTS: The high dose (1000 mg/kg) of ASB significantly increased the MDA content, but decreased the SOD activity as compared to the control mice. The proteomic analysis revealed that 6 proteins were differentially expressed in the high-dose group. Two stress-responsive proteins, ie heat shock cognate 71 kDa protein (HSC70) and peroxiredoxin-6 (PRDX6), were regulated at the expression level. The remaining 4 proteins involving in cellular energy metabolism, including isoforms of methylmalonyl-coenzyme A mutase (MUT), nucleoside diphosphate-linked moiety X motif 19 (Nudix motif19), mitochondrial NADH dehydrogenase 1 alpha subcomplex subunit 10 (NDUFA10) and nucleoside diphosphate kinase B (NDK B), were modified at the post-translational levels.
CONCLUSION: Our findings suggest that the mitochondrion is the primary target of ASB and that ASB-induced nephrotoxicity results from oxidative stress mediated by superoxide produced by complex I.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21685926      PMCID: PMC4003128          DOI: 10.1038/aps.2011.39

Source DB:  PubMed          Journal:  Acta Pharmacol Sin        ISSN: 1671-4083            Impact factor:   6.150


  32 in total

Review 1.  Reactive oxygen species and acute renal failure.

Authors:  K A Nath; S M Norby
Journal:  Am J Med       Date:  2000-12-01       Impact factor: 4.965

2.  Proteomic analysis of mouse kidney peroxisomes: identification of RP2p as a peroxisomal nudix hydrolase with acyl-CoA diphosphatase activity.

Authors:  Rob Ofman; Dave Speijer; René Leen; Ronald J A Wanders
Journal:  Biochem J       Date:  2006-01-15       Impact factor: 3.857

3.  Oxidative modification of nucleoside diphosphate kinase and its identification by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry.

Authors:  E J Song; Y S Kim; J Y Chung; E Kim; S K Chae; K J Lee
Journal:  Biochemistry       Date:  2000-08-22       Impact factor: 3.162

Review 4.  Mitochondrial free radical generation, oxidative stress, and aging.

Authors:  E Cadenas; K J Davies
Journal:  Free Radic Biol Med       Date:  2000-08       Impact factor: 7.376

5.  Reversible glutathionylation of complex I increases mitochondrial superoxide formation.

Authors:  Ellen R Taylor; Fiona Hurrell; Richard J Shannon; Tsu-Kung Lin; Judy Hirst; Michael P Murphy
Journal:  J Biol Chem       Date:  2003-03-20       Impact factor: 5.157

6.  Up-regulation of the peroxiredoxin-6 related metabolism of reactive oxygen species in skeletal muscle of mice lacking neuronal nitric oxide synthase.

Authors:  Luis Da Silva-Azevedo; Sebastian Jähne; Christian Hoffmann; Daniel Stalder; Manfred Heller; Axel R Pries; Andreas Zakrzewicz; Oliver Baum
Journal:  J Physiol       Date:  2008-12-01       Impact factor: 5.182

7.  A mitochondrial protein compendium elucidates complex I disease biology.

Authors:  David J Pagliarini; Sarah E Calvo; Betty Chang; Sunil A Sheth; Scott B Vafai; Shao-En Ong; Geoffrey A Walford; Canny Sugiana; Avihu Boneh; William K Chen; David E Hill; Marc Vidal; James G Evans; David R Thorburn; Steven A Carr; Vamsi K Mootha
Journal:  Cell       Date:  2008-07-11       Impact factor: 41.582

8.  Peroxiredoxin-6 protects against mitochondrial dysfunction and liver injury during ischemia-reperfusion in mice.

Authors:  Thorsten Eismann; Nadine Huber; Thomas Shin; Satoshi Kuboki; Elizabeth Galloway; Michael Wyder; Michael J Edwards; Kenneth D Greis; Howard G Shertzer; Aron B Fisher; Alex B Lentsch
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2008-11-25       Impact factor: 4.052

9.  Analysis of peroxiredoxin decreasing oxidative stress in hypertensive aortic smooth muscle.

Authors:  Chang-Kwon Lee; Hyo Jin Kim; Youn Ri Lee; Hyeon Ha So; Hyo-Jun Park; Kyung-Jong Won; Taekyu Park; Kyung-Yung Lee; Hwan Myung Lee; Bokyung Kim
Journal:  Biochim Biophys Acta       Date:  2007-05-10

10.  Nucleoside diphosphate kinase (NDPK, NM23, AWD): recent regulatory advances in endocytosis, metastasis, psoriasis, insulin release, fetal erythroid lineage and heart failure; translational medicine exemplified.

Authors:  Anil Mehta; Sandra Orchard
Journal:  Mol Cell Biochem       Date:  2009-05-05       Impact factor: 3.396

View more
  4 in total

1.  Andrographolide Sulfonate Attenuates Acute Lung Injury by Reducing Expression of Myeloperoxidase and Neutrophil-Derived Proteases in Mice.

Authors:  Fei Gao; Xing Liu; Ziying Shen; Xiaohui Jia; Han He; Jing Gao; Jianhong Wu; Chunhong Jiang; Hu Zhou; Yiping Wang
Journal:  Front Physiol       Date:  2018-08-17       Impact factor: 4.566

Review 2.  Andrographis paniculata Formulations: Impact on Diterpene Lactone Oral Bioavailability.

Authors:  João Paulo Loureiro Damasceno; Hemerson Silva da Rosa; Luciana Silva de Araújo; Niege Araçari Jacometti Cardoso Furtado
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2021-11-23       Impact factor: 2.569

3.  Proteomic characterization of acyclovir-induced nephrotoxicity in a mouse model.

Authors:  Hong Lu; Ya-Juan Han; Jia-Dong Xu; Wen-Min Xing; Jie Chen
Journal:  PLoS One       Date:  2014-07-23       Impact factor: 3.240

Review 4.  Andrographolide, a Natural Antioxidant: An Update.

Authors:  Eugenie Mussard; Annabelle Cesaro; Eric Lespessailles; Brigitte Legrain; Sabine Berteina-Raboin; Hechmi Toumi
Journal:  Antioxidants (Basel)       Date:  2019-11-20
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.